EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Acute Adverse Effects of Therapeutic Doses of Psilocybin

Akhila Yerubandi, Jennifer E Thomas, N M Mahmudul Alam Bhuiya, Catherine Harrington, Lorenzo Villa Zapata, Joshua Caballero

JAMA Network Open · 10.04.2024 · 7 (4) · e245960

DOI: 10.1001/jamanetworkopen.2024.5960 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JAMA Network Open, online erschienen am 10.04.2024. Verfasst von Akhila Yerubandi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Athens. Hauptthemen laut MEDLINE: Psilocybin, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Psilocybin has been studied in the treatment of depression and anxiety disorders. Clinical studies have mainly focused on efficacy, with systematic reviews showing favorable efficacy; however, none have primarily focused on psilocybin safety.

Objective

To evaluate the acute adverse effects of psilocybin at therapeutic doses in the treatment of depression and anxiety. Data Sources MEDLINE via PubMed, Web of Science, and ClinicalTrials.gov were searched for publications available between 1966 and November 30, 2023. Study Selection Randomized, double-blind clinical trials that reported adverse effects of psilocybin in patients treated for depression and anxiety were screened. Data Extraction and Synthesis Data were independently extracted by 2 authors and verified by 2 additional authors following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. The inverse variance method with the Hartung-Knapp adjustment for the random-effects model was used, with a continuity correction of 0.5 for studies with 0 cell frequencies. Sensitivity analysis was conducted by sequentially removing 1 study at a time to assess the robustness of the results. Main Outcomes and Measures The primary outcome was considered as the adverse effects of psilocybin at high and moderate (ie, therapeutic) dose regimens and compared with placebo, low-dose psilocybin, or other comparator in the treatment of depression and/or anxiety.

Results

Six studies met the inclusion criteria with a total sample of 528 participants (approximately 51% female; median age 39.8 years; IQR, 39.8-41.2). Seven adverse effects were reported in multiple studies and included in the analysis. Among these, headache (relative risk [RR], 1.99; 95% CI 1.06-3.74), nausea (RR, 8.85; 95% CI, 5.68-13.79), anxiety (RR, 2.27; 95% CI, 1.11-4.64), dizziness (RR, 5.81; 95% CI, 1.02-33.03), and elevated blood pressure (RR, 2.29; 95% CI, 1.15- 4.53) were statistically significant. Psilocybin use was not associated with risk of paranoia and transient thought disorder. Conclusions and Relevance In this meta-analysis, the acute adverse effect profile of therapeutic single-dose psilocybin appeared to be tolerable and resolved within 48 hours. However, future studies need to more actively evaluate the appropriate management of adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsilocybinDrug-Related Side Effects and Adverse ReactionsHumansFemaleAdultMaleAnxiety DisordersAnxietyDizzinessRandomized Controlled Trials as Topic

Substanzen

Psilocybin

Autor:innen und Institutionen

  • Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Athens.
  • Department of Clinical and Administrative Sciences, Larkin University, Miami, Florida.
  • Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida.

Zitieren

APA

Yerubandi, A., Thomas, J. E., Bhuiya, N. M. M. A., Harrington, C., Villa Zapata, L., & Caballero, J. (2024). Acute Adverse Effects of Therapeutic Doses of Psilocybin. JAMA Network Open, 7(4), e245960. https://doi.org/10.1001/jamanetworkopen.2024.5960

Vancouver

Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. Acute Adverse Effects of Therapeutic Doses of Psilocybin. JAMA Network Open. 2024;7(4):e245960. doi:10.1001/jamanetworkopen.2024.5960

BibTeX
@article{Yerubandi2024,
  author = {Yerubandi, Akhila and Thomas, Jennifer E and Bhuiya, N M Mahmudul Alam and Harrington, Catherine and Villa Zapata, Lorenzo and Caballero, Joshua},
  title = {Acute Adverse Effects of Therapeutic Doses of Psilocybin},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {4},
  pages = {e245960},
  doi = {10.1001/jamanetworkopen.2024.5960}
}
Kostenlos starten →